Studies on the Development of Medications for Treating Osteoporosis:Synthesis of β-(p-((N-Alkanoylprolyl)amino)benzyl) D-Glucosaminepyranoside with Various Length of Alkanoic Acids and Its Biological Activity
碩士 === 中原大學 === 化學研究所 === 101 === Glycolipid compounds GPS-1 (18), GS (18), and GO (18) synthesized in our laboratory , we found that GPS-3 (18) than the other two high GS (18) and GO (18). After comparing the three structural differences, we GPS-1 (18) is the lead compound (lead compound), Synthesi...
Main Authors: | , |
---|---|
Other Authors: | |
Format: | Others |
Language: | zh-TW |
Published: |
2013
|
Online Access: | http://ndltd.ncl.edu.tw/handle/60156381378013131761 |
id |
ndltd-TW-101CYCU5065081 |
---|---|
record_format |
oai_dc |
spelling |
ndltd-TW-101CYCU50650812015-10-13T22:40:30Z http://ndltd.ncl.edu.tw/handle/60156381378013131761 Studies on the Development of Medications for Treating Osteoporosis:Synthesis of β-(p-((N-Alkanoylprolyl)amino)benzyl) D-Glucosaminepyranoside with Various Length of Alkanoic Acids and Its Biological Activity 治療骨質疏鬆症藥物的開發研究:具不同碳數飽和羧酸的β-(對-((N-烷醯脯胺醯)胺基)苄基)D-葡萄糖胺苷的合成及其生物活性 Yen-Yu Lin 林晏右 碩士 中原大學 化學研究所 101 Glycolipid compounds GPS-1 (18), GS (18), and GO (18) synthesized in our laboratory , we found that GPS-3 (18) than the other two high GS (18) and GO (18). After comparing the three structural differences, we GPS-1 (18) is the lead compound (lead compound), Synthesized a series ofsaturated fatty acids with differrent carbon number of glycolipid compoundsGPS-1 series, explore a systematic relationship between the structure andbiological activity (structure-acti- vety relationship, SAR). GPS-1 series of compounds is N-acetyl glucosamine (glucosamine) as a starting material, via a plurality of oxide acetylation (per-O-acetylation), cyclization reaction (cyclization), glycosylation reaction (glycosylation) , N-tertiary-butoxycarbonyl-amidation reaction (amidization) and the hydrogenation reaction (hydrogenation) and other five steps to prepare the compound GS-5.Compound GS-5 and then with FMOC-L-proline (Fmoc-L-Proline) conductedamidation reaction (amidization), then de 9-fluorenyl methoxycarbonyl(fluorenylmethyloxycarbonyl, Fmoc) reacts with different unsaturated carboxylic acid amide having a carbon number of the amination reaction, and thedeacetylation reaction to tert-butoxycarbonyl (t-butyloxycarbonyl, Boc) reaction, the five-step reaction to obtain the target GPS-1. Activity test parts: for a single dose (10 μM) of the activity test, we found thispart of a series of compounds has a significant inhibitory effect, but some with no apparent biological significance, and not because of the length of the carbon chain showed a correlation , visibility, influence the activity of the carbon chain is not the main reason. In addition, we have also done a multiple dose (10,20,30 μM) activity test and found that this series of compounds at concentrationsincrease, the correct time will increase its inhibitory activity. Yow-Fu Tsai 蔡祐輔 2013 學位論文 ; thesis 194 zh-TW |
collection |
NDLTD |
language |
zh-TW |
format |
Others
|
sources |
NDLTD |
description |
碩士 === 中原大學 === 化學研究所 === 101 === Glycolipid compounds GPS-1 (18), GS (18), and GO (18) synthesized in our laboratory , we found that GPS-3 (18) than the other two high GS (18) and GO (18). After comparing the three structural differences, we GPS-1 (18) is the lead compound (lead compound), Synthesized a series ofsaturated fatty acids with differrent carbon number of glycolipid compoundsGPS-1 series, explore a systematic relationship between the structure andbiological activity (structure-acti-
vety relationship, SAR).
GPS-1 series of compounds is N-acetyl glucosamine (glucosamine) as a starting material, via a plurality of oxide acetylation (per-O-acetylation), cyclization reaction (cyclization), glycosylation reaction (glycosylation)
, N-tertiary-butoxycarbonyl-amidation reaction (amidization) and the hydrogenation reaction (hydrogenation) and other five steps to prepare the compound GS-5.Compound GS-5 and then with FMOC-L-proline
(Fmoc-L-Proline) conductedamidation reaction (amidization), then de 9-fluorenyl methoxycarbonyl(fluorenylmethyloxycarbonyl, Fmoc) reacts with different unsaturated carboxylic acid amide having a carbon number of the amination reaction, and thedeacetylation reaction to tert-butoxycarbonyl
(t-butyloxycarbonyl, Boc) reaction, the five-step reaction to obtain the target GPS-1.
Activity test parts: for a single dose (10 μM) of the activity test, we found
thispart of a series of compounds has a significant inhibitory effect, but some
with no apparent biological significance, and not because of the length of the carbon chain showed a correlation , visibility, influence the activity of the carbon chain is not the main reason. In addition, we have also done a multiple dose (10,20,30 μM) activity test and found that this series of compounds at concentrationsincrease, the correct time will increase its
inhibitory activity.
|
author2 |
Yow-Fu Tsai |
author_facet |
Yow-Fu Tsai Yen-Yu Lin 林晏右 |
author |
Yen-Yu Lin 林晏右 |
spellingShingle |
Yen-Yu Lin 林晏右 Studies on the Development of Medications for Treating Osteoporosis:Synthesis of β-(p-((N-Alkanoylprolyl)amino)benzyl) D-Glucosaminepyranoside with Various Length of Alkanoic Acids and Its Biological Activity |
author_sort |
Yen-Yu Lin |
title |
Studies on the Development of Medications for Treating Osteoporosis:Synthesis of β-(p-((N-Alkanoylprolyl)amino)benzyl) D-Glucosaminepyranoside with Various Length of Alkanoic Acids and Its Biological Activity |
title_short |
Studies on the Development of Medications for Treating Osteoporosis:Synthesis of β-(p-((N-Alkanoylprolyl)amino)benzyl) D-Glucosaminepyranoside with Various Length of Alkanoic Acids and Its Biological Activity |
title_full |
Studies on the Development of Medications for Treating Osteoporosis:Synthesis of β-(p-((N-Alkanoylprolyl)amino)benzyl) D-Glucosaminepyranoside with Various Length of Alkanoic Acids and Its Biological Activity |
title_fullStr |
Studies on the Development of Medications for Treating Osteoporosis:Synthesis of β-(p-((N-Alkanoylprolyl)amino)benzyl) D-Glucosaminepyranoside with Various Length of Alkanoic Acids and Its Biological Activity |
title_full_unstemmed |
Studies on the Development of Medications for Treating Osteoporosis:Synthesis of β-(p-((N-Alkanoylprolyl)amino)benzyl) D-Glucosaminepyranoside with Various Length of Alkanoic Acids and Its Biological Activity |
title_sort |
studies on the development of medications for treating osteoporosis:synthesis of β-(p-((n-alkanoylprolyl)amino)benzyl) d-glucosaminepyranoside with various length of alkanoic acids and its biological activity |
publishDate |
2013 |
url |
http://ndltd.ncl.edu.tw/handle/60156381378013131761 |
work_keys_str_mv |
AT yenyulin studiesonthedevelopmentofmedicationsfortreatingosteoporosissynthesisofbpnalkanoylprolylaminobenzyldglucosaminepyranosidewithvariouslengthofalkanoicacidsanditsbiologicalactivity AT línyànyòu studiesonthedevelopmentofmedicationsfortreatingosteoporosissynthesisofbpnalkanoylprolylaminobenzyldglucosaminepyranosidewithvariouslengthofalkanoicacidsanditsbiologicalactivity AT yenyulin zhìliáogǔzhìshūsōngzhèngyàowùdekāifāyánjiūjùbùtóngtànshùbǎohésuōsuāndebduìnwánxīpúànxīànjībiànjīdpútáotángàngāndehéchéngjíqíshēngwùhuóxìng AT línyànyòu zhìliáogǔzhìshūsōngzhèngyàowùdekāifāyánjiūjùbùtóngtànshùbǎohésuōsuāndebduìnwánxīpúànxīànjībiànjīdpútáotángàngāndehéchéngjíqíshēngwùhuóxìng |
_version_ |
1718079115841503232 |